Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$116.35+4.35 (+3.88%)
Close on Nov 18, 2026Market cap $7.30BP/E –Yield –
Twist Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Twist Bioscience's total debt was $0 at Sep 30, 2022. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $9.72M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $0 | -100.0% |
| FY2021 | Sep 30, 2021 | $1.55M | -67.2% |
| FY2020 | Sep 30, 2020 | $4.74M | -38.8% |
| FY2019 | Sep 30, 2019 | $7.73M | -20.4% |
| FY2018 | Sep 30, 2018 | $9.72M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $0 | -100.0% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $1.55M | -67.2% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $2.37M | -57.0% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $3.17M | -49.4% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $3.96M | -43.5% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.74M | -38.8% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $5.50M | -34.9% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $6.26M | -31.7% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $7.00M | -29.0% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $7.73M | -20.4% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $8.45M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $9.16M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $9.86M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $9.72M | – |
See a number that looks wrong?